Company Filing History:
Years Active: 2010
Title: Inventor Jesper Haaning: Innovator in Therapeutic Vaccination
Introduction
Jesper Haaning is a prominent inventor based in Birkerød, Denmark. With a focus on advancing therapeutic applications in immunology, he holds two notable patents that contribute significantly to the field of cancer treatment and vaccine development. His innovative methods aim to enhance the immune response against weak cellular antigens, particularly in the context of cancer.
Latest Patents
Jesper Haaning's latest patents provide groundbreaking methods for therapeutic vaccination. These inventions focus on inducing cell-mediated immunity against cellular antigens by employing a method that enhances cytotoxic T-lymphocyte immunity against weak antigens, which include self-proteins, specifically targeting cancer-specific antigens such as PSM, Her2, and FGF8b. The patented methods enable antigen-presenting cells to showcase at least one CTL epitope of the weak antigen while simultaneously presenting a foreign T-helper lymphocyte epitope. This versatile method can be implemented through traditional polypeptide vaccinations, as well as live attenuated vaccines or nucleic acid vaccinations. The inventions also encompass immunogenic analogues of the identified targets, nucleic acid molecules encoding these analogues, and methodologies for identifying immunogenic analogues of weak or non-immunogenic antigens.
Career Highlights
Jesper's commitment to innovation is exemplified through his work with Bn Immunotherapeutics, Inc., where he actively contributes to cutting-edge research and development in immunotherapy. His forward-thinking approaches are pivotal in shaping new strategies for cancer treatment and vaccination.
Collaborations
Throughout his career, Jesper Haaning has collaborated with notable professionals in the field, including Lucilla Steinaa and Søren Mouritsen. These partnerships reflect his dedication to advancing therapeutic methodologies and leveraging collective expertise in the pursuit of innovative medical solutions.
Conclusion
In summary, Jesper Haaning's contributions to the realm of therapeutic vaccination mark him as a key figure in modern medical innovation. Through his patents and collaborative efforts, he continues to pave the way for enhanced immunotherapeutic strategies, ultimately aiming to improve patient outcomes in cancer treatment.